Top Markets
Coin of the day
Medeon Biodesign, Inc. Medeon Biodesign, Inc.

Medeon Biodesign, Inc.

6499
株式のランク #17677
Medeon Biodesign, Inc. engages in the research and development, manufacturing,... Medeon Biodesign, Inc. engages in the research and development, manufacturing, and sale of medical devices in the United States. The company focuses on developing devices for minimally invasive surgeries, such as Cross-Seal, a large bore vascular closure system; Urocross, an expander system for treating lower urinary tract symptoms associated with benign prostatic hyperplasia; Duett, a vascular graft system; PUMA, solution to treat orthopedic extremity injuries; ClickClean, a solution to view throughout laparoscopic surgeries; and AbClose to prevent port site herniation caused by improper closure. It is engaged in the medical device contract manufacturing; and manufacture and sale of injection molding and components of medical devices. Medeon Biodesign, Inc. was incorporated in 2012 and is based in Taipei, Taiwan.
株価
$2.38
時価総額
$231.21M
変化(1日)
0.94%
変化(1年)
-25.60%
TW
取引 Medeon Biodesign, Inc. (6499)

カテゴリー

Medeon Biodesign, Inc.(6499)の利益
2026 時点の利益 TTM: 0
Medeon Biodesign, Inc. の最新の財務報告によると、同社の現在の利益は 0 です。2026 年には 0 の利益を上げ、これは 2026 年の利益 0 と 同等 です。このページに表示されている利益は、利息および税引き前利益、すなわち EBIT です。
Medeon Biodesign, Inc. の利益の推移(2026 〜 2026)
各年末の利益
利益 変化
提供された日付のデータは十分ではありません。
同業他社の利益